Simultaneous inhibition of ATR and PARP greatly sensitizes colon cancer cell lines to irinotecan

被引：0
|
作者：
Davidson, David [1 ]
Abu-Sanad, Atlal [1 ]
Wang, Yunzhe [1 ]
Hasheminasab, Fatemeh [1 ]
Panasci, Justin [1 ]
Aloyz, Raquel [1 ]
Panasci, Lawrence [1 ]
机构：
[1] McGill Univ, Jewish Gen Hosp, Lady Davis Insitute, Segal Canc Ctr, Montreal, PQ H3T 1E2, Canada
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-5327
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5327
引用
收藏
页数：3
相关论文
共 50 条
  • [31] PTEN deficiency sensitizes endometrioid endometrial cancer to compound PARP-PI3K inhibition but not PARP inhibition as monotherapy
    Bian, X.
    Gao, J.
    Luo, F.
    Rui, C.
    Zheng, T.
    Wang, D.
    Wang, Y.
    Roberts, T. M.
    Liu, P.
    Zhao, J. J.
    Cheng, H.
    ONCOGENE, 2018, 37 (03) : 341 - 351
  • [32] PTEN deficiency sensitizes endometrioid endometrial cancer to compound PARP-PI3K inhibition but not PARP inhibition as monotherapy
    X Bian
    J Gao
    F Luo
    C Rui
    T Zheng
    D Wang
    Y Wang
    T M Roberts
    P Liu
    J J Zhao
    H Cheng
    Oncogene, 2018, 37 : 341 - 351
  • [33] ATM Loss Confers Greater Sensitivity to ATR Inhibition Than PARP Inhibition in Prostate Cancer
    Rafiei, Shahrzad
    Fitzpatrick, Kenyon
    Liu, David
    Cai, Mu-Yan
    Elmarakeby, Haitham A.
    Park, Jihye
    Ricker, Cora
    Kochupurakkal, Bose S.
    Choudhury, Atish D.
    Hahn, William C.
    Balk, Steven P.
    Hwang, Justin H.
    Van Allen, Eliezer M.
    Mouw, Kent W.
    CANCER RESEARCH, 2020, 80 (11) : 2094 - 2100
  • [34] Synergistic action of combined PARP and ATR inhibition in prostate cancer with ATM loss
    Tregunna R.
    Nature Reviews Urology, 2021, 18 (1) : 4 - 4
  • [35] PARP inhibition sensitizes endometrial cancer cells to paclitaxel-induced apoptosis
    Dinkic, Christine
    Jahn, Friederike
    Zygmunt, Marek
    Schuetz, Florian
    Rom, Joachim
    Sohn, Christof
    Fluhr, Herbert
    ONCOLOGY LETTERS, 2017, 13 (04) : 2847 - 2851
  • [36] Imipridones exhibit synergy with sorafenib, HDAC inhibition, PARP inhibition, and proteasome inhibition in liver cancer cell lines.
    Honeyman, Joshua N.
    Chang, Wen-I
    Prabhu, Varun V.
    Allen, Joshua E.
    Zhou, Lanlan
    El-Deiry, Wafik S.
    CANCER RESEARCH, 2021, 81 (13)
  • [37] Combined PARP and ATR inhibition potentiates genome instability and cell death in ATM-deficient cancer cells
    Lloyd, Rebecca L.
    Wijnhoven, Paul W. G.
    Ramos-Montoya, Antonio
    Wilson, Zena
    Illuzzi, Giuditta
    Falenta, Katarzyna
    Jones, Gemma N.
    James, Neil
    Chabbert, Christophe D.
    Stott, Jonathan
    Dean, Emma
    Lau, Alan
    Young, Lucy A.
    ONCOGENE, 2020, 39 (25) : 4869 - 4883
  • [38] Combined PARP and ATR inhibition potentiates genome instability and cell death in ATM-deficient cancer cells
    Rebecca L. Lloyd
    Paul W. G. Wijnhoven
    Antonio Ramos-Montoya
    Zena Wilson
    Giuditta Illuzzi
    Katarzyna Falenta
    Gemma N. Jones
    Neil James
    Christophe D. Chabbert
    Jonathan Stott
    Emma Dean
    Alan Lau
    Lucy A. Young
    Oncogene, 2020, 39 : 4869 - 4883
  • [39] Simultaneous activation and inhibition of autophagy sensitizes cancer cells to chemotherapy
    Chi, Kwan-Hwa
    Wang, Yu-Shan
    Huang, Yi-Chun
    Chiang, Hsin-Chien
    Chi, Mau-Shin
    Chi, Chau-Hwa
    Wang, Hsin-Ell
    Kao, Shang-Jyh
    ONCOTARGET, 2016, 7 (36) : 58075 - 58088
  • [40] The synergistic potential of PARP inhibitors and irinotecan in small cell lung cancer
    Oh, Songji
    Kim, Miso
    Kim, Soyeon
    Keam, Bhumsuk
    Youk, Jeonghwan
    Kim, Tae Min
    Kim, Dong-Wan
    Heo, Dae Seog
    CANCER RESEARCH, 2024, 84 (06)
12345